Cargando…

Cohort Profile: IAVI’s HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery

Detalles Bibliográficos
Autores principales:	Price, Matt A, Kilembe, William, Ruzagira, Eugene, Karita, Etienne, Inambao, Mubiana, Sanders, Eduard J, Anzala, Omu, Allen, Susan, Edward, Vinodh A, Kaleebu, Pontiano, Fast, Patricia E, Rida, Wasima, Kamali, Anatoli, Hunter, Eric, Tang, Jianming, Lakhi, Shabir, Mutua, Gaudensia, Bekker, Linda Gail, Abu-Baker, Ggayi, Tichacek, Amanda, Chetty, Paramesh, Latka, Mary H, Maenetje, Pholo, Makkan, Heeran, Hare, Jonathan, Kibengo, Freddie, Priddy, Fran, Landais, Elise, Chinyenze, Kundai, Gilmour, Jill
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Cohort Profiles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938500/ https://www.ncbi.nlm.nih.gov/pubmed/32879950 http://dx.doi.org/10.1093/ije/dyaa100

Ejemplares similares

Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection
por: Price, Matt A, et al.
Publicado: (2019)

Creating an African HIV Clinical Research and Prevention Trials Network: HIV Prevalence, Incidence and Transmission
por: Kamali, Anatoli, et al.
Publicado: (2015)

Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries
por: Wall, Kristin M., et al.
Publicado: (2017)

Attitudes Toward Gender-Based Violence Among Sexually Active Adult Men at High Risk for HIV in Rustenburg, South Africa
por: Makkan, Heeran, et al.
Publicado: (2022)

Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya
por: Omosa-Manyonyi, Gloria, et al.
Publicado: (2014)

Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya
por: Muturi, Margaret, et al.
Publicado: (2006)

Prediction of extended high viremia among newly HIV-1-infected persons in sub-Saharan Africa
por: Powers, Kimberly A., et al.
Publicado: (2018)

Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda
por: Mayanja, Yunia, et al.
Publicado: (2023)

HIV incidence and predictors of inconsistent condom use among adult men enrolled into an HIV vaccine preparedness study, Rustenburg, South Africa
por: Maenetje, Pholo, et al.
Publicado: (2019)

Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa
por: Sanders, Eduard J., et al.
Publicado: (2017)

Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers
por: Mutua, Gaudensia, et al.
Publicado: (2012)

Failure of A Novel, Rapid Antigen and Antibody Combination Test to Detect Antigen-Positive HIV Infection in African Adults with Early HIV Infection
por: Kilembe, William, et al.
Publicado: (2012)

Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia
por: Malama, Kalonde, et al.
Publicado: (2022)

Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya
por: Mutua, Gaudensia, et al.
Publicado: (2019)

Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya
por: Mugo, Peter Mwangi, et al.
Publicado: (2014)

Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
por: Nyaoke, Borna A., et al.
Publicado: (2017)

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa
por: Amornkul, Pauli N., et al.
Publicado: (2013)

Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial
por: Mpendo, Juliet, et al.
Publicado: (2020)

A cluster randomized trial to reduce HIV risk from outside partnerships in Zambian HIV-Negative couples using a novel behavioral intervention, “Strengthening Our Vows”: Study protocol and baseline data
por: Sharkey, Tyronza, et al.
Publicado: (2021)

Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value
por: Abaasa, Andrew, et al.
Publicado: (2017)

Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
por: Landais, Elise, et al.
Publicado: (2016)

P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India
por: Kochhar, S, et al.
Publicado: (2009)

Transitioning couple’s voluntary HIV counseling and testing (CVCT) from stand-alone weekend services into routine antenatal and VCT services in government clinics in Zambia’s two largest cities
por: Inambao, Mubiana, et al.
Publicado: (2017)

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults
por: Mutua, Gaudensia, et al.
Publicado: (2016)

422. Pooling Strategy for Chlamydia trachomatis and Neisseria gonorrhoeae Reduces Cost of GeneXpert Molecular STI Screening in Two Limited-Resource Clinics in Zambia
por: Connolly, Sarah, et al.
Publicado: (2019)

Pregnancy Incidence and Correlates in a Clinical Trial Preparedness Study, North West Province South Africa
por: Chetty-Makkan, Candice M., et al.
Publicado: (2014)

Cost‐effectiveness of couples’ voluntary HIV counselling and testing in six African countries: a modelling study guided by an HIV prevention cascade framework
por: Wall, Kristin M, et al.
Publicado: (2020)

Performance of self-reported adherence to oral pre-exposure prophylaxis (PrEP) among HIV heterosexual serodiscordant couples in rural Uganda
por: Kibengo, FM, et al.
Publicado: (2012)

The Use of Isolated Human Lymphocytes in Mycotoxin Cytotoxicity Testing
por: Maenetje, Pholo W., et al.
Publicado: (2008)

Accelerating HIV vaccine development through meaningful engagement of local scientists and communities
por: Chinyenze, Kundai, et al.
Publicado: (2023)

Comparing the Novel Method of Assessing PrEP Adherence/Exposure Using Hair Samples to Other Pharmacologic and Traditional Measures
por: Baxi, Sanjiv M., et al.
Publicado: (2015)

HIV testing and counselling couples together for affordable HIV prevention in Africa
por: Wall, Kristin M, et al.
Publicado: (2019)

Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial
por: Kibengo, Freddie M., et al.
Publicado: (2013)

High Transmitter CD4+ T-Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant Couples
por: Karita, Etienne, et al.
Publicado: (2015)

Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya
por: Mutisya, Elizabeth Mueni, et al.
Publicado: (2020)

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa
por: Ngongo, BP, et al.
Publicado: (2012)

Couples’ voluntary HIV counseling and testing provider training evaluation, Zambia
por: Wu, Kathleen Y, et al.
Publicado: (2018)

Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults—Experience from Kenya
por: Nyasani, Delvin Kwamboka, et al.
Publicado: (2018)

HIV vaccines in 2022: where to from here?
por: Hannah, Stacey, et al.
Publicado: (2022)

Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya
por: Mutisya, Elizabeth Mueni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_30brj926n585jsssoirf7k7d40